Oestern H J, Kabus K
Klinik für Unfall- und Wiederherstellungschirurgie, Allgemeines Krankenhaus Celle.
Unfallchirurg. 1994 Apr;97(4):177-84.
Among the more than 50 scoring systems available for quantitative evaluation of injury severity, only a few have proved effective in clinical practice. In particular, the Revised Trauma Score (RTS), referring to physiological variables, has proved effective in preclinical use and otherwise, the Injury Severity Score (ISS), referring to anatomical data. There is a tendency in the development of new scoring systems to aim at higher predictive accuracy, forfeiting practicability. The initial purpose of scoring--an early assessment of the risks--is being pushed into the background. The TRISS method, which includes the RTS, ISS, patient's age, and mechanism of injury, is regarded as the international standard. However, it has the disadvantage of a low sensitivity of 60% for blunt trauma, resulting in a high rate of unexpected deaths. Reasons for this are underestimation of head injuries, multiple injuries to one body region, and failure to take full account of the individual patient's age. The new ASCOT method, in which the ISS is replaced by the Anatomic Profile, and the age of the patient is given more consideration, hardly brings better results--in spite of quite time-consuming methods. When the scoring systems currently available are applied their specific deficiencies and limited evidence must be borne in mind. Nevertheless, they are an important scientific instrument for comparative examinations, and indispensable for quality assurance and economic analyses. To improve the predictive accuracy, biochemical parameters and chronic diseases should be considered, in addition to existing scores.
在可用于定量评估损伤严重程度的50多种评分系统中,只有少数几种在临床实践中被证明是有效的。特别是,修订创伤评分(RTS),涉及生理变量,已被证明在临床前使用中有效,另外,损伤严重程度评分(ISS),涉及解剖学数据。新评分系统的发展趋势是追求更高的预测准确性,而牺牲实用性。评分的最初目的——早期风险评估——正被置于次要地位。包括RTS、ISS、患者年龄和损伤机制的TRISS方法被视为国际标准。然而,它有一个缺点,即对钝性创伤的敏感性低至60%,导致意外死亡率很高。原因是对头部损伤的低估、身体一个区域的多处损伤以及没有充分考虑个体患者的年龄。新的ASCOT方法,用解剖学概况取代了ISS,并更多地考虑了患者的年龄,尽管方法相当耗时,但几乎没有带来更好的结果。当应用目前可用的评分系统时,必须牢记它们的特定缺陷和有限的证据。尽管如此,它们是比较检查的重要科学工具,对于质量保证和经济分析是不可或缺的。为了提高预测准确性,除了现有的评分外,还应考虑生化参数和慢性病。